RP-L102

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Lentiviral-mediated Gene Therapy for Pediatric Patients With Fanconi Anemia Subtype ANCT04069533RCKTPhase 2Unknown2025-02Estimated
Gene Therapy for Fanconi Anemia, Complementation Group ANCT04248439RCKTPhase 2Active not recruiting2026-05-05Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.